The studies are part of an ongoing research program on the causes and consequences of human aggression by Bushman, who is also affiliated with VU University Amsterdam conducted.
Scientists believe that cientists have developed a new molecular sensor that measures the amount of zinc in cells, which could tell us can show a number of diseases, including type 2 diabetes – Molecular Sensor Could Reveal Zinc role in diseases. The research, published in Nature Methods, opens the door to the hidden world of zinc biology by scientists. An accurate method for measuring the concentration of zinc and its location in cells for the first time.With support from two trusts – Charley’s discovery and the Nash Avery Foundation – the Galapagos being currently reviewing the potential efficacy GLPG0492 preclinical models Duchenne muscular dystrophy. ‘GLPG0492 selected fifth drug candidates clinic clinic of Galapagos since initiating our first clinical trial in March of 2009,’said Onno van de Stolpe, CEO from Galapagos. A once-daily an improvement of the muscle mass in the pre-clinical studies the potential to the potential recognized in the treatment of diseases where losing muscle ground is heavy, such as cachexia and Duchenne.’..